Publications by authors named "S Pelissier"
Study protocol for two stepped-wedge interventional trials evaluating the effects of holistic information technology-based patient-oriented management in older multimorbid patients with cancer: The GERONTE trials.
J Geriatr Oncol
May 2024
Article Synopsis
- * The study aims to implement a new patient-centered care pathway that involves a collaborative team of healthcare professionals to better address the needs of these older patients.
- * Conducted as a multicentric trial across Europe, the GERONTE study will compare the outcomes of patients receiving this new care approach with those who receive standard oncologic care.
Article Synopsis
- Stereotactic body radiotherapy (SBRT) is emerging as a treatment option for localized prostate cancer, but research supporting its effectiveness is still developing.
- Many clinical studies have been conducted, but there is a lack of standardization in treatment methods, target areas, and dosage limits across these studies.
- The French Genito-Urinary Group (GETUG) provides recommendations based on the existing research, acknowledging the need for more consistent evidence in SBRT for prostate cancer.
Using surveillance data to understand cancer trends: an overview in Morocco.
Arch Public Health
November 2015
Background: The aim was to use the existing surveillance data sources of cancer in Morocco that could be used to better describe cancer mortality and incidence trends in Morocco.
Methods: National incidence data were derived from population-based cancer registries. Mortality data were collected from the international GLOBOCAN database.
The clinical validity of circulating tumor cell (CTC) count changes during chemotherapy in metastatic breast cancer patients has been validated, but its clinical utility remains to be demonstrated. We report here the non-randomized run-in phase of the CirCe01 trial which was designed to evaluate CTC changes and thresholds to other palliative prognostic scores and establish CTC thresholds to be used in the randomized part of the study. CTC count (CellSearch®) and other prognostic parameters (serum albumin level, lymphocyte level, LDH level, prognostic inflammatory and nutritional index (PINI) and Barbot's score) were assessed in 56 metastatic breast cancer patients before the first cycle of third line chemotherapy.
View Article and Find Full Text PDFBackground: Intensive surveillance in women at intermediate and high breast cancer risk is currently investigated in a French prospective, non-randomized, multicentre study. Two surveillance modalities, standard imaging-mammography ± ultrasound ('Mx')-or standard imaging with magnetic resonance imaging ('MRI'), provided according to the level of breast cancer risk, are compared on psychological distress.
Methods: A total of 1561 women were invited to complete the State-Trait Anxiety Inventory (STAI), Impact of Event Scale (IES) Intrusion and Avoidance subscales and breast cancer-risk perception items at T0 (before examination) and T2 (1 to 3 months later) and the STAI-State anxiety at T1 (just after examination).